UTAH MEDICAL PRODUCTS INC

UTMD ·Healthcare, Medical Devices, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2009
Operating Activities
Net Income $6.3M
Depreciation & Amortization
Depreciation $555.0K
Amortization
Stock-Based Compensation $98.0K
Net Cash from Operating Activities $7.2M
Investing Activities
Capital Expenditures $466.0K
Business Acquisitions
Net Cash from Investing Activities $-3.2M
Financing Activities
Dividends Paid $3.3M
Stock Repurchases
Net Cash from Financing Activities $-3.8M
Net Change in Cash $313.0K
Free Cash Flow $6.8M
← Newer Page 3 of 3 Older →